| Univariate |  |  | Multivariate |  |  |
---|---|---|---|---|---|---|
p value | HR | 95% CI | p value | HR | 95% CI | |
Age, years (≥50 vs. < 50) | 0.73 | 0.89 | 0.47–1.68 |  |  |  |
Pre-NAC clinical stage (stage I and II vs. stage III) | < 0.01 | 3.1 | 1.58–5.81 | < 0.01 | 2.17 | 1.57–7.27 |
ER (positive vs. negative) | 0.97 | 1.1 | 0.48–2.14 |  |  |  |
HER2 (positive vs. negative) | 0.012 | 0.3 | 0.11–0.77 | 0.016 | 0.28 | 0.10–0.79 |
ΔPNI (high vs. low) | 0.018 | 2.2 | 1.14–4.41 | 0.042 | 2.17 | 1.08–4.76 |
ΔAlb (high vs. low) | 0.058 | 1.9 | 0.97–3.52 |  |  |  |
ΔBMI (high vs. low) | 0.66 | 0.87 | 0.45–1.63 |  |  |  |
ΔNLR (high vs. low) | 0.66 | 1.2 | 0.61–2.18 |  |  |  |
Histological type (IDC vs. ILC or special type) | 0.23 | 2.4 | 0.58–10.03 |  |  |  |
Pathological response to NAC (non-pCR vs. pCR) | 0.19 | 0.64 | 0.32–1.25 |  |  |  |